If Amgen really believes that NEO is going to be the real deal then in my opinion if I were them I would be in talks with ADXS about a buyout or in talks about another deal with HOT before other competitors come along and try to make a deal. Amgen knows more than anyone what’s really going on with NEO and I’m pretty sure they don’t want another BP coming along and making a deal for HOT. Dan O Conner was really surprised that Amgen didn’t buy HOT too! I believe they weren’t too worried about hot until they dosed the 1st patient with NEO then Amgen would have more clarity with HOT after they dosed and got back trial results with NEO. Too many want shareholders to think ADXS has flawed science when in fact we just might have the answers to many types of cancer our future is now in the hands of Amgen and that just fine with me! If Amgen sees what NEO can do don’t think for a moment they are going to low ball Advaxis they have tons of cash and want NEO to knock it out of the park . I’m telling you all you have to look at ADXS as a new investment from this point forward, forget about the money you’ve already invested look at this as another opportunity to regain any losses that you have incurred in the past. We are all awaiting news on NEO trial ...it will makes us or Break us! Place your bets! Seems our Lm platform is pretty darn safe and effective if past trials are any indication.
News 
Market Data 
Discover 
